相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Human Immunopeptidome Project: A Roadmap to Predict and Treat Immune Diseases
Juan Antonio Vizcaino et al.
MOLECULAR & CELLULAR PROTEOMICS (2020)
IPD-IMGT/HLA Database
James Robinson et al.
NUCLEIC ACIDS RESEARCH (2020)
VDJdb in 2019: database extension, new analysis infrastructure and a T-cell receptor motif compendium
Dmitry Bagaev et al.
NUCLEIC ACIDS RESEARCH (2020)
Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes
Chloe Chong et al.
NATURE COMMUNICATIONS (2020)
Endogenous TAP-independent MHC-I antigen presentation: not just the ER lumen
Margarita Del Val et al.
CURRENT OPINION IN IMMUNOLOGY (2020)
APE-Gen: A Fast Method for Generating Ensembles of Bound Peptide-MHC Conformations
Jayvee R. Abella et al.
MOLECULES (2019)
Turning the corner on therapeutic cancer vaccines
Robert E. Hollingsworth et al.
NPJ VACCINES (2019)
ACME: pan-specific peptide-MHC class I binding prediction through attention-based deep neural networks
Yan Hu et al.
BIOINFORMATICS (2019)
Efficacy and Safety Analysis of Nelipepimut-S Vaccine to Prevent Breast Cancer Recurrence: A Randomized, Multicenter, Phase III Clinical Trial
Elizabeth A. Mittendorf et al.
CLINICAL CANCER RESEARCH (2019)
Mass spectrometry based identification of MHC-bound peptides for immunopeptidomics
Anthony W. Purcell et al.
NATURE PROTOCOLS (2019)
DeepLigand: accurate prediction of MHC class I ligands using peptide embedding
Haoyang Zeng et al.
BIOINFORMATICS (2019)
Combination of CTLA-4 and PD-1 blockers for treatment of cancer
Anand Rotte
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Quantitative Prediction of the Landscape of T Cell Epitope Immunogenicity in Sequence Space
Masato Ogishi et al.
FRONTIERS IN IMMUNOLOGY (2019)
Quantification of Uncertainty in Peptide-MHC Binding Prediction Improves High-Affinity Peptide Selection for Therapeutic Design
Haoyang Zeng et al.
CELL SYSTEMS (2019)
Cancer Testis Antigens and Immunotherapy: Where Do We Stand in the Targeting of PRAME?
Ghaneya Al-Khadairi et al.
CANCERS (2019)
TCR-like antibodies in cancer immunotherapy
Qinghua He et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Proteogenomic discovery of cancer antigens: Neoantigens and beyond
Takayuki Kanaseki et al.
PATHOLOGY INTERNATIONAL (2019)
NNAlign_MA; MHC Peptidome Deconvolution for Accurate MHC Binding Motif Characterization and Improved T-cell Epitope Predictions
Bruno Alvarez et al.
MOLECULAR & CELLULAR PROTEOMICS (2019)
TCRpMHCmodels: Structural modelling of TCR-pMHC class I complexes
Kamilla Kjaergaard Jensen et al.
SCIENTIFIC REPORTS (2019)
Cancer Neoantigens
Ton N. Schumacher et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 37, 2019 (2019)
Detection of Enriched T Cell Epitope Specificity in Full T Cell Receptor Sequence Repertoires
Sofie Gielis et al.
FRONTIERS IN IMMUNOLOGY (2019)
DeepHLApan: A Deep Learning Approach for Neoantigen Prediction Considering Both HLA-Peptide Binding and Immunogenicity
Jingcheng Wu et al.
FRONTIERS IN IMMUNOLOGY (2019)
Peptide-Major Histocompatibility Complex Class I Binding Prediction Based on Deep Learning With Novel Feature
Tianyi Zhao et al.
FRONTIERS IN GENETICS (2019)
The Immune Epitope Database (IEDB): 2018 update
Randi Vita et al.
NUCLEIC ACIDS RESEARCH (2019)
MS-Rescue: A Computational Pipeline to Increase the Quality and Yield of Immunopeptidomics Experiments
Massimo Andreatta et al.
PROTEOMICS (2019)
Cold Tumors: A Therapeutic Challenge for Immunotherapy
Paola Bonaventura et al.
FRONTIERS IN IMMUNOLOGY (2019)
Proteogenomics: advances in cancer antigen research
Takayuki Kanaseki et al.
IMMUNOLOGICAL MEDICINE (2019)
High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) Ligandome
Chloe Chong et al.
MOLECULAR & CELLULAR PROTEOMICS (2018)
STCRDab: the structural T-cell receptor database
Jinwoo Leem et al.
NUCLEIC ACIDS RESEARCH (2018)
VDJdb: a curated database of T-cell receptor sequences with known antigen specificity
Mikhail Shugay et al.
NUCLEIC ACIDS RESEARCH (2018)
Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation
Markus W. Loeffler et al.
CANCER RESEARCH (2018)
The Role of Mass Spectrometry and Proteogenomics in the Advancement of HLA Epitope Prediction
Amanda L. Creech et al.
PROTEOMICS (2018)
General Prediction of Peptide-MHC Binding Modes Using Incremental Docking: A Proof of Concept
Dinler A. Antunes et al.
SCIENTIFIC REPORTS (2018)
HERVs New Role in Cancer: From Accused Perpetrators to Cheerful Protectors
Norbert Bannert et al.
FRONTIERS IN MICROBIOLOGY (2018)
NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
Remy Thomas et al.
FRONTIERS IN IMMUNOLOGY (2018)
MHCflurry: Open-Source Class I MHC Binding Affinity Prediction
Timothy J. O'Donnell et al.
CELL SYSTEMS (2018)
Human endogenous retroviruses and their implication for immunotherapeutics of cancer
A. S. Attermann et al.
ANNALS OF ONCOLOGY (2018)
Cytosolic Processing Governs TAP-Independent Presentation of a Critical Melanoma Antigen
Nathalie Vigneron et al.
JOURNAL OF IMMUNOLOGY (2018)
Estimating the Contribution of Proteasomal Spliced Peptides to the HLA-1 Ligandome
Roman Mylonas et al.
MOLECULAR & CELLULAR PROTEOMICS (2018)
Epigenetic regulation of MAGE family in human cancer progression-DNA methylation, histone modification, and non-coding RNAs
Yishui Lian et al.
CLINICAL EPIGENETICS (2018)
Predicting Antigen Presentation - What Could We Learn From a Million Peptides?
David Gfeller et al.
FRONTIERS IN IMMUNOLOGY (2018)
GradDock: rapid simulation and tailored ranking functions for peptide-MHC Class I docking
Hyun-Ho Kyeong et al.
BIOINFORMATICS (2018)
Immunotherapy against cancer-related viruses
Haruko Tashiro et al.
CELL RESEARCH (2017)
A Case for a Human Immuno-Peptidome Project Consortium
Etienne Caron et al.
IMMUNITY (2017)
NetMHCpan-4.0: Improved Peptide-MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data
Vanessa Jurtz et al.
JOURNAL OF IMMUNOLOGY (2017)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens
Michael S. Khodadoust et al.
NATURE (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
GibbsCluster: unsupervised clustering and alignment of peptide sequences
Massimo Andreatta et al.
NUCLEIC ACIDS RESEARCH (2017)
ATLAS: A database linking binding affinities with structures for wild-type and mutant TCR-pMHC complexes
Tyler Borrman et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2017)
Soluble HLA-associated peptide from PSF1 has a cancer vaccine potency
Mari Yoshida et al.
SCIENTIFIC REPORTS (2017)
Identification of Glycopeptides as Posttranslationally Modified Neoantigens in Leukemia
Stacy A. Malaker et al.
CANCER IMMUNOLOGY RESEARCH (2017)
PSSMHCpan: a novel PSSM-based software for predicting class I peptide-HLA binding affinity
Geng Liu et al.
GIGASCIENCE (2017)
McPAS-TCR: a manually curated catalogue of pathology-associated T cell receptor sequences
Nili Tickotsky et al.
BIOINFORMATICS (2017)
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy
Antoni Ribas et al.
CELL (2017)
Cancer vaccines in the era of checkpoint blockade: the magic is in the adjuvant
Willem W. Overwijk
CURRENT OPINION IN IMMUNOLOGY (2017)
Evolution of MHC-based technologies used for detection of antigen-responsive T cells
Amalie Kai Bentzen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Gapped sequence alignment using artificial neural networks: application to the MHC class I system
Massimo Andreatta et al.
BIOINFORMATICS (2016)
Detection of an Immunogenic HERV-E Envelope with Selective Expression in Clear Cell Kidney Cancer
Elena Cherkasova et al.
CANCER RESEARCH (2016)
Mass spectrometry-based antigen discovery for cancer immunotherapy
Michal Bassani-Sternberg et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
The development and use of the E75 (HER2 369-377) peptide vaccine
Guy T. Clifton et al.
FUTURE ONCOLOGY (2016)
Unsupervised HLA Peptidome Deconvolution Improves Ligand Prediction Accuracy and Predicts Cooperative Effects in Peptide-HLA Interactions
Michal Bassani-Sternberet et al.
JOURNAL OF IMMUNOLOGY (2016)
Pan-Specific Prediction of Peptide-MHC Class I Complex Stability, a Correlate of T Cell Immunogenicity
Michael Rasmussen et al.
JOURNAL OF IMMUNOLOGY (2016)
The Length Distribution of Class I-Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele-Specific Binding Preference
Thomas Trolle et al.
JOURNAL OF IMMUNOLOGY (2016)
Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
Michal Bassani-Sternberg et al.
NATURE COMMUNICATIONS (2016)
Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens
Shelly Kalaora et al.
ONCOTARGET (2016)
Global burden of cancers attributable to infections in 2012: a synthetic analysis
Martyn Plummer et al.
LANCET GLOBAL HEALTH (2016)
Immune responses to endogenous retroelements: taking the bad with the good
George Kassiotis et al.
NATURE REVIEWS IMMUNOLOGY (2016)
CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
Shannon L. Maude et al.
BLOOD (2015)
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
Michael S. Rooney et al.
CELL (2015)
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
Padmanee Sharma et al.
CELL (2015)
The MAGE protein family and cancer
Jenny L. Weon et al.
CURRENT OPINION IN CELL BIOLOGY (2015)
An overview of bioinformatics tools for epitope prediction: Implications on vaccine development
Ruth E. Soria-Guerra et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2015)
Tumor neoantigens: building a framework for personalized cancer immunotherapy
Matthew M. Gubin et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Landscape of Tumor Antigens in T Cell Immunotherapy
Sadia Ilyas et al.
JOURNAL OF IMMUNOLOGY (2015)
LYRA, a webserver for lymphocyte receptor structural modeling
Michael Schantz Klausen et al.
NUCLEIC ACIDS RESEARCH (2015)
Adoptive cell transfer as personalized immunotherapy for human cancer
Steven A. Rosenberg et al.
SCIENCE (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
DockTope: a Web-based tool for automated pMHC-I modelling
Mauricio Menegatti Rigo et al.
SCIENTIFIC REPORTS (2015)
Immunoinformatics and epitope prediction in the age of genomic medicine
Linus Backert et al.
GENOME MEDICINE (2015)
Human Tumor Antigens and Cancer Immunotherapy
Nathalie Vigneron
BIOMED RESEARCH INTERNATIONAL (2015)
Role of peptide processing predictions in T cell epitope identification: contribution of different prediction programs
Jorg J. A. Calis et al.
IMMUNOGENETICS (2015)
Accurate Prediction of Immunogenic T-Cell Epitopes from Epitope Sequences Using the Genetic Algorithm-Based Ensemble Learning
Wen Zhang et al.
PLOS ONE (2015)
HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL)
Daniel J. Kowalewski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein-Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer
Graham S. Taylor et al.
CLINICAL CANCER RESEARCH (2014)
NetTepi: an integrated method for the prediction of T cell epitopes
Thomas Trolle et al.
IMMUNOGENETICS (2014)
NETMHCSTAB - predicting stability of peptide-MHC-I complexes; impacts for cytotoxic T lymphocyte epitope discovery
Kasper W. Jorgensen et al.
IMMUNOLOGY (2014)
Accurate quantitation of MHC-bound peptides by application of isotopically labeled peptide MHC complexes
Chopie Hassan et al.
JOURNAL OF PROTEOMICS (2014)
Direct Interrogation of Viral Peptides Presented by the Class I HLA of HIV-Infected T Cells
Jane C. Yaciuk et al.
JOURNAL OF VIROLOGY (2014)
Proteogenomics: concepts, applications and computational strategies
Alexey I. Nesvizhskii
NATURE METHODS (2014)
Immunotherapeutic Agents in Non-small-cell Lung Cancer Finally Coming to the Front Lines
Rossana Ruiz et al.
CURRENT ONCOLOGY REPORTS (2014)
Simultaneous alignment and clustering of peptide data using a Gibbs sampling approach
Massimo Andreatta et al.
BIOINFORMATICS (2013)
Discovering naturally processed antigenic determinants that confer protective T cell immunity
Pavlo Gilchuk et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
PAAQD: Predicting immunogenicity of MHC class I binding peptides using amino acid pairwise contact potentials and quantum topological molecular similarity descriptors
Thammakorn Saethang et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2013)
Comparison of Vaccine-Induced Effector CD8 T Cell Responses Directed against Self- and Non-Self-Tumor Antigens: Implications for Cancer Immunotherapy
Sara R. Pedersen et al.
JOURNAL OF IMMUNOLOGY (2013)
Human Papillomavirus Type 16 E6/E7-specific Cytotoxic T Lymphocytes for Adoptive Immunotherapy of HPV-associated Malignancies
Carlos A. Ramos et al.
JOURNAL OF IMMUNOTHERAPY (2013)
Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
Richard A. Morgan et al.
JOURNAL OF IMMUNOTHERAPY (2013)
Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity
Cor H. J. Lamers et al.
MOLECULAR THERAPY (2013)
Properties of MHC Class I Presented Peptides That Enhance Immunogenicity
Jorg J. A. Calis et al.
PLOS COMPUTATIONAL BIOLOGY (2013)
Abacavir induces loading of novel self-peptides into HLA-B*57:01: an autoimmune model for HLA-associated drug hypersensitivity
Michael A. Norcross et al.
AIDS (2012)
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells
James N. Kochenderfer et al.
BLOOD (2012)
NetMHCcons: a consensus method for the major histocompatibility complex class I predictions
Edita Karosiene et al.
IMMUNOGENETICS (2012)
Secreted HLA recapitulates the immunopeptidome and allows in-depth coverage of HLA A*02:01 ligands
Katherine E. Scull et al.
MOLECULAR IMMUNOLOGY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cells
Concetta Quintarelli et al.
BLOOD (2011)
POPISK: T-cell reactivity prediction using support vector machines and string kernels
Chun-Wei Tung et al.
BMC BIOINFORMATICS (2011)
Insights into the processing of MHC class I ligands gained from the study of human tumor epitopes
Nathalie Vigneron et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
The biology of cancer testis antigens: Putative function, regulation and therapeutic potential
Elisabetta Fratta et al.
MOLECULAR ONCOLOGY (2011)
T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
Maria R. Parkhurst et al.
MOLECULAR THERAPY (2011)
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
Padmanee Sharma et al.
NATURE REVIEWS CANCER (2011)
Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19
James N. Kochenderfer et al.
BLOOD (2010)
HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase
Brian M. Olson et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
The SSX Family of Cancer-Testis Antigens as Target Proteins for Tumor Therapy
Heath A. Smith et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2010)
NetCTLpan: pan-specific MHC class I pathway epitope predictions
Thomas Stranzl et al.
IMMUNOGENETICS (2010)
Soluble plasma HLA peptidome as a potential source for cancer biomarkers
Michal Bassani-Sternberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The Impact of HER2/neu Expression Level on Response to the E75 Vaccine: From US Military Cancer Institute Clinical Trials Group Study I-01 and I-02
Linda C. Benavides et al.
CLINICAL CANCER RESEARCH (2009)
Characterization of Genetically Modified T-Cell Receptors that Recognize the CEA:691-699 Peptide in the Context of HLA-A2.1 on Human Colorectal Cancer Cells
Maria R. Parkhurst et al.
CLINICAL CANCER RESEARCH (2009)
MAGRIT: The Largest-Ever Phase III Lung Cancer Trial Aims to Establish a Novel Tumor-Specific Approach to Therapy
Preeta Tyagi et al.
CLINICAL LUNG CANCER (2009)
CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens
Luiz Gonzaga Almeida et al.
NUCLEIC ACIDS RESEARCH (2009)
HLA class I molecules consistently present internal influenza epitopes
Angela Wahl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
HLA class I supertypes: a revised and updated classification
John Sidney et al.
BMC IMMUNOLOGY (2008)
Epitope landscape in breast and colorectal cancer
Neil H. Segal et al.
CANCER RESEARCH (2008)
Features of TAP-independent MHC class I ligands revealed by quantitative mass spectrometry
Andreas O. Weinzierl et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells (vol 118, pg 1099, 2008)
Yoshiyuki Takahashi et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
EBV-associated lymphoproliferative disorders: Classification and treatment
Antonino Carbone et al.
ONCOLOGIST (2008)
AAindex: amino acid index database, progress report 2008
Shuichi Kawashima et al.
NUCLEIC ACIDS RESEARCH (2008)
NetMHCpan, a Method for Quantitative Predictions of Peptide Binding to Any HLA-A and -B Locus Protein of Known Sequence
Morten Nielsen et al.
PLOS ONE (2007)
Drug therapy: Trastuzumab - Mechanism of action and use in clinical practice
Clifford A. Hudis
NEW ENGLAND JOURNAL OF MEDICINE (2007)
POPI: predicting immunogenicity of MHC class I binding peptides by mining informative physicochemical properties
Chun-Wei Tung et al.
BIOINFORMATICS (2007)
In ovarian cancer the prognostic influence of HER2/neu is not dependent on the CXCR4/SDF-1 signalling pathway
D. Pils et al.
BRITISH JOURNAL OF CANCER (2007)
Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy
Angela L. Zarling et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Detection of T lymphocytes specific for human endogenous retrovirus K (HERV-K) in patients with seminoma
S Rakoff-Nahoum et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2006)
Generation of RAGE-1 and MAGE-9 peptide-specific cytotoxic T-lymphocyte lines for transfer in patients with renal cell carcinoma
N Oehlrich et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Cancer/testis antigens, gametogenesis and cancer
AJG Simpson et al.
NATURE REVIEWS CANCER (2005)
An integrative approach to CTL epitope prediction: A combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions
MV Larsen et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage
M Nielsen et al.
IMMUNOGENETICS (2005)
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans
ID Davis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Proteogenomic mapping as a complementary method to perform genome annotation
JD Jaffe et al.
PROTEOMICS (2004)
Events that led to the discovery of T-cell development and function - a personal recollection
JFAP Miller
TISSUE ANTIGENS (2004)
Identifying MHC class I epitopes by predicting the TAP transport efficiency of epitope precursors
B Peters et al.
JOURNAL OF IMMUNOLOGY (2003)
Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells
SM Schmidt et al.
BLOOD (2003)
Prediction of proteasome cleavage motifs by neural networks
C Kesmir et al.
PROTEIN ENGINEERING (2002)
Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein
RE Clark et al.
BLOOD (2001)
Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules
J Sidney et al.
HUMAN IMMUNOLOGY (2001)
Efficient identification of novel HLA-A*0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis
JH Kessler et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Phosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivo
AL Zarling et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Melanocyte destruction after antigen-specific immunotherapy of melanoma: Direct evidence of T cell-mediated vitiligo
C Yee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Immunodominance among EBV-derived epitopes restricted by HLA-B27 does not correlate with epitope abundance in EBV-transformed B-lymphoblastoid cell lines
VL Crotzer et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
